118 related articles for article (PubMed ID: 18778441)
1. Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion.
Semba J; Wakuta M
Psychiatry Clin Neurosci; 2008 Aug; 62(4):435-41. PubMed ID: 18778441
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of prodynophin, c-fos, and serotonin transporter mRNA following withdrawal from a chronic, escalating dose regimen of D-amphetamine.
Horner KA; Noble ES; Lauterbach EC
Synapse; 2009 Apr; 63(4):257-68. PubMed ID: 19116947
[TBL] [Abstract][Full Text] [Related]
3. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
David SP; Niaura R; Papandonatos GD; Shadel WG; Burkholder GJ; Britt DM; Day A; Stumpff J; Hutchison K; Murphy M; Johnstone E; Griffiths SE; Walton RT
Nicotine Tob Res; 2003 Dec; 5(6):935-42. PubMed ID: 14668077
[TBL] [Abstract][Full Text] [Related]
4. Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.
Biala G; Kruk M
J Pharm Pharmacol; 2009 Apr; 61(4):493-502. PubMed ID: 19298697
[TBL] [Abstract][Full Text] [Related]
5. Bupropion for the treatment of nicotine withdrawal and craving.
Mooney ME; Sofuoglu M
Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112
[TBL] [Abstract][Full Text] [Related]
6. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.
El Mansari M; Ghanbari R; Janssen S; Blier P
Neuropharmacology; 2008 Dec; 55(7):1191-8. PubMed ID: 18708076
[TBL] [Abstract][Full Text] [Related]
7. Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration.
Rauhut AS; Dwoskin LP; Bardo MT
Nicotine Tob Res; 2005 Dec; 7(6):901-7. PubMed ID: 16298725
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
Sidhpura N; Redfern P; Rowley H; Heal D; Wonnacott S
Biochem Pharmacol; 2007 Oct; 74(8):1292-8. PubMed ID: 17678630
[TBL] [Abstract][Full Text] [Related]
9. Rate-dependent effects of bupropion on nicotine self-administration and food-maintained responding in rats.
Stairs DJ; Dworkin SI
Pharmacol Biochem Behav; 2008 Oct; 90(4):701-11. PubMed ID: 18602678
[TBL] [Abstract][Full Text] [Related]
10. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
Paterson NE; Balfour DJ; Markou A
Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
[TBL] [Abstract][Full Text] [Related]
11. The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses.
Cheeta S; Irvine EE; Kenny PJ; File SE
Psychopharmacology (Berl); 2001 Apr; 155(1):78-85. PubMed ID: 11374339
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat.
Ferrie L; Young AH; McQuade R
J Psychopharmacol; 2005 May; 19(3):229-34. PubMed ID: 15888507
[TBL] [Abstract][Full Text] [Related]
13. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
Cryan JF; Bruijnzeel AW; Skjei KL; Markou A
Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231
[TBL] [Abstract][Full Text] [Related]
14. L-DOPA attenuates nicotine withdrawal-induced behaviors in rats.
Ohmura Y; Jutkiewicz EM; Domino EF
Pharmacol Biochem Behav; 2011 Jun; 98(4):552-8. PubMed ID: 21354201
[TBL] [Abstract][Full Text] [Related]
15. Involvement of pre- and post-synaptic serotonergic receptors of dorsal raphe nucleus neural network in the control of the sweet-substance-induced analgesia in adult Rattus norvegicus (Rodentia, Muridae).
Miyase CI; Kishi R; de Freitas RL; Paz DA; Coimbra NC
Neurosci Lett; 2005 May; 379(3):169-73. PubMed ID: 15843057
[TBL] [Abstract][Full Text] [Related]
16. Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
Paterson NE; Balfour DJ; Markou A
Nicotine Tob Res; 2008 Jun; 10(6):995-1008. PubMed ID: 18584463
[TBL] [Abstract][Full Text] [Related]
17. A unique role for striatal serotonergic systems in the withdrawal from adolescent nicotine administration.
Slotkin TA; Seidler FJ
Neurotoxicol Teratol; 2007; 29(1):10-6. PubMed ID: 16919421
[TBL] [Abstract][Full Text] [Related]
18. Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.
Malin DH; Moon WD; Goyarzu P; Magallanes N; Blair MB; Alexander MR; McDavid L; Spurgeon JL; Ennifar S; Fattom A
Nicotine Tob Res; 2010 Apr; 12(4):438-44. PubMed ID: 20203107
[TBL] [Abstract][Full Text] [Related]
19. Bupropion attenuates nicotine abstinence syndrome in the rat.
Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
[TBL] [Abstract][Full Text] [Related]
20. Participation of dorsal raphe nucleus in the behavioral alteration observed after discontinuation of chronic diazepam administration: possible neural circuitry involved.
Almirón RS; Ramírez OA
Synapse; 2005 May; 56(2):61-8. PubMed ID: 15714479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
